Hinge Health Reports 53% Revenue Growth to $154.2 Million in Latest Quarter

Hinge Health, Inc. reported significant financial growth in its latest quarterly filing, with revenue reaching $154.2 million for the three months ended September 30, 2025, a 53% increase from $100.6 million in the same period last year. For the nine months ending September 30, 2025, revenue also grew by 53% to $417.1 million, compared to $273.1 million in the prior year. Despite this growth, the company recorded a net loss of $1.8 million for the third quarter, a decline from a net income of $341,000 in the same quarter of 2024. The nine-month net loss was $560.4 million, significantly higher than the $39.0 million loss reported in the previous year, primarily due to increased stock-based compensation expenses related to the company's initial public offering (IPO).

The company’s operational metrics showed a notable increase in client engagement, with the total number of clients rising to 2,560 as of September 30, 2025, up from 2,047 a year earlier. This growth contributed to an increase in contracted lives, which reached approximately 20 million, up from 16 million in the previous year. Hinge Health's calculated billings for the last twelve months also increased to $624.2 million, compared to $416.9 million a year prior, reflecting the company's expanding market presence and client base.

Strategically, Hinge Health completed its IPO in May 2025, raising approximately $255.7 million in net proceeds, which were primarily used to cover employee taxes related to the settlement of restricted stock units. The IPO was accompanied by a significant restructuring of the company's stock structure, including the conversion of preferred stock into common stock, which streamlined its equity framework. The company has also focused on enhancing its product offerings, including the launch of new programs and the integration of advanced AI technologies to improve member engagement and care delivery.

Operationally, Hinge Health reported a substantial increase in expenses, with total operating expenses for the third quarter rising to $132.3 million, up from $83.1 million in the same quarter of 2024. This increase was driven by higher research and development costs, sales and marketing expenses, and general administrative costs, largely attributed to stock-based compensation related to the IPO. The company’s gross profit for the third quarter was $126.2 million, resulting in a gross margin of 82%, up from 79% in the previous year, indicating improved operational efficiency.

Looking ahead, Hinge Health remains optimistic about its growth trajectory, emphasizing its commitment to innovation and expansion into new markets. The company plans to continue leveraging its AI-driven platform to enhance member outcomes and reduce costs for clients, while also exploring opportunities for geographic expansion and new product development. However, management acknowledges the challenges posed by macroeconomic conditions and the need to effectively manage growth and operational costs to achieve sustained profitability.